Canaan IX L.P., Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 13,253 shares at $10.00 ($134K) on 2016-05-24, disclosed to the SEC on 2016-05-25.
Open-market sale of $134k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.10 | 12,053 | $122K | 91.0% |
| 2 | $10.00 | 1,200 | $12K | 9.0% |
| Total | $10.09 avg | 13,253 | $134K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-14 | $1.9M | — | Filing → |